Intellectual property rights must be violated in order to ensure global vaccine access.
Vaccine access is critical for developing global immunity against COVID-19, but low and middle-income countries (LMICs) are currently facing significant barriers to access. Intellectual property rights (IPRs) are a crucial obstacle for global vaccine access. Rather than making vaccines freely available, IPRs prioritise industry profits over human health and well-being.
Recent Comments